IS5406A - Samsetning 5-HT endurupptökuhemils og h5-HT1B mótlyfs eða gerandefnis með hlutaverkun - Google Patents

Samsetning 5-HT endurupptökuhemils og h5-HT1B mótlyfs eða gerandefnis með hlutaverkun

Info

Publication number
IS5406A
IS5406A IS5406A IS5406A IS5406A IS 5406 A IS5406 A IS 5406A IS 5406 A IS5406 A IS 5406A IS 5406 A IS5406 A IS 5406A IS 5406 A IS5406 A IS 5406A
Authority
IS
Iceland
Prior art keywords
agonist
composition
reuptake inhibitor
partial action
ht1b antagonist
Prior art date
Application number
IS5406A
Other languages
English (en)
Inventor
Berg Stefan
Ross Svante
Thorberg Seth-Olov
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IS5406A publication Critical patent/IS5406A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Replacement Of Web Rolls (AREA)
  • Winding, Rewinding, Material Storage Devices (AREA)
IS5406A 1997-09-18 2000-03-15 Samsetning 5-HT endurupptökuhemils og h5-HT1B mótlyfs eða gerandefnis með hlutaverkun IS5406A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9703375A SE9703375D0 (sv) 1997-09-18 1997-09-18 A new combination
PCT/SE1998/001601 WO1999013877A1 (en) 1997-09-18 1998-09-09 A COMBINATION OF A 5-HT REUPTAKE INHIBITOR AND A h5-HT1B ANTAGONIST OR PARTIAL AGONIST

Publications (1)

Publication Number Publication Date
IS5406A true IS5406A (is) 2000-03-15

Family

ID=20408295

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5406A IS5406A (is) 1997-09-18 2000-03-15 Samsetning 5-HT endurupptökuhemils og h5-HT1B mótlyfs eða gerandefnis með hlutaverkun

Country Status (29)

Country Link
US (1) US6159971A (is)
EP (1) EP1014985B1 (is)
JP (1) JP2001516718A (is)
KR (1) KR20010024076A (is)
CN (1) CN1195519C (is)
AR (1) AR015448A1 (is)
AT (1) ATE240733T1 (is)
AU (1) AU752722B2 (is)
BR (1) BR9812088A (is)
CA (1) CA2302382A1 (is)
DE (1) DE69814882T2 (is)
DK (1) DK1014985T3 (is)
EE (1) EE04141B1 (is)
ES (1) ES2200370T3 (is)
HU (1) HUP0200602A3 (is)
IL (1) IL134776A0 (is)
IS (1) IS5406A (is)
MY (1) MY116280A (is)
NO (1) NO20001399L (is)
NZ (1) NZ503171A (is)
PL (1) PL339371A1 (is)
PT (1) PT1014985E (is)
RU (1) RU2214824C2 (is)
SE (1) SE9703375D0 (is)
SK (1) SK2852000A3 (is)
TR (1) TR200000727T2 (is)
TW (1) TW589183B (is)
WO (1) WO1999013877A1 (is)
ZA (1) ZA987817B (is)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9601110D0 (sv) * 1996-03-22 1996-03-22 Astra Ab Substituted 1,2,3,4-tetrahydronaphthalene derivatives
AR021155A1 (es) * 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
UA77650C2 (en) * 1999-12-06 2007-01-15 Lundbeck & Co As H Use of serotonin reuptake inhibitor in combination with deramcyclane
WO2002066454A1 (fr) * 2001-02-21 2002-08-29 Sankyo Company, Limited Derives de chromene
EA200301195A1 (ru) * 2001-05-01 2004-04-29 Х. Лундбекк А/С Применение энантиомерно чистого эсциталопрама
US7504395B2 (en) * 2001-07-20 2009-03-17 Psychogenics, Inc. Treatment for attention-deficit hyperactivity disorder
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
SE0203778D0 (sv) * 2002-12-09 2002-12-09 Astrazeneca Ab A new oral immediated release dosage form
AR047553A1 (es) 2003-07-04 2006-01-25 Lundbeck & Co As H La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina
KR100511288B1 (ko) * 2003-11-14 2005-08-31 엘지전자 주식회사 4대의 압축기를 구비한 공기조화기의 실외기
WO2006091725A1 (en) * 2005-02-23 2006-08-31 The Silvan S. Tomkins Institute Treatment of anhedonia
ES2646326T3 (es) 2005-08-03 2017-12-13 Sprout Pharmaceuticals, Inc. Uso de flibanserina en el tratamiento de la obesidad
FR2890862B1 (fr) * 2005-09-19 2008-01-25 Sanofi Aventis Sa Association d'agoniste aux recepteurs beta 3 et d'inhibiteur de la recapture de monoamnies, compostion pharmaceutique la contenant et son utilisation en therapeutique.
WO2007048803A1 (en) 2005-10-29 2007-05-03 Boehringer Ingelheim International Gmbh Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
RU2455981C2 (ru) * 2006-06-16 2012-07-20 Теракос, Инк. Лечение ожирения антагонистами мускаринового рецептора м1
US7893053B2 (en) 2006-06-16 2011-02-22 Theracos, Inc. Treating psychological conditions using muscarinic receptor M1 antagonists
US8748419B2 (en) 2006-06-16 2014-06-10 Theracos, Inc. Treating obesity with muscarinic receptor M1 antagonists
WO2008000760A1 (en) 2006-06-30 2008-01-03 Boehringer Ingelheim International Gmbh Flibanserin for the treatment of urinary incontinence and related diseases
BRPI0716439B8 (pt) 2006-08-14 2021-05-25 Boehringer Ingelheim Int sistemas de liberação farmacêutico compreendendo flibanserina, processo para preparação e uso dos mesmos
CL2007002214A1 (es) 2006-08-14 2008-03-07 Boehringer Ingelheim Int Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp
BRPI0716436B8 (pt) 2006-08-25 2021-05-25 Boehringer Ingelheim Int sistema de liberação controlada e método para fabricação do mesmo
CL2008002693A1 (es) 2007-09-12 2009-10-16 Boehringer Ingelheim Int Uso de flibanserina para el tratamiento de sintomas vasomotores seleccionados de sofocos, sudores nocturnos, cambios de estado de animo e irritabilidad

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9119932D0 (en) * 1991-09-18 1991-10-30 Glaxo Group Ltd Chemical compounds
DK0533268T3 (da) * 1991-09-18 2001-12-03 Glaxo Group Ltd Benzanilidderivater som 5HT-1D antagonister
SE9601110D0 (sv) * 1996-03-22 1996-03-22 Astra Ab Substituted 1,2,3,4-tetrahydronaphthalene derivatives
SE9703374D0 (sv) * 1997-09-18 1997-09-18 Astra Ab A new combination

Also Published As

Publication number Publication date
SK2852000A3 (en) 2000-09-12
AU752722B2 (en) 2002-09-26
CN1195519C (zh) 2005-04-06
US6159971A (en) 2000-12-12
ZA987817B (en) 1999-03-18
HK1032739A1 (en) 2001-08-03
NZ503171A (en) 2002-02-01
ES2200370T3 (es) 2004-03-01
EE04141B1 (et) 2003-10-15
DK1014985T3 (da) 2003-09-15
MY116280A (en) 2003-12-31
DE69814882T2 (de) 2004-05-19
TW589183B (en) 2004-06-01
NO20001399D0 (no) 2000-03-17
TR200000727T2 (tr) 2000-09-21
RU2214824C2 (ru) 2003-10-27
PT1014985E (pt) 2003-10-31
DE69814882D1 (de) 2003-06-26
EP1014985A1 (en) 2000-07-05
CN1278729A (zh) 2001-01-03
WO1999013877A1 (en) 1999-03-25
IL134776A0 (en) 2001-04-30
CA2302382A1 (en) 1999-03-25
AR015448A1 (es) 2001-05-02
EP1014985B1 (en) 2003-05-21
PL339371A1 (en) 2000-12-18
EE200000141A (et) 2001-02-15
HUP0200602A3 (en) 2003-04-28
BR9812088A (pt) 2000-09-26
ATE240733T1 (de) 2003-06-15
HUP0200602A2 (hu) 2002-07-29
NO20001399L (no) 2000-05-10
JP2001516718A (ja) 2001-10-02
KR20010024076A (ko) 2001-03-26
SE9703375D0 (sv) 1997-09-18
AU9193098A (en) 1999-04-05

Similar Documents

Publication Publication Date Title
EE04141B1 (et) 5-HT tagasihaarde inhibiitori kombinatsioon h5-HT1B antagonisti või osalise agonistiga
HUP0203586A3 (en) The combination of a serotonin reuptake inhibitor and a 5-ht2c antagonist, inverse agonist or partial agonist
NO20022334L (no) Ny sammensetning og anvendelse
NO20013393L (no) Bronnsementeringsfremgangsmater og sammensetninger
NO973046L (no) Elastiske brönnsementsammensetninger og fremgangsmåter
DK1112003T3 (da) Ny sammensætning og anvendelse
EE200000146A (et) Monoamiini oksüdaasi inhibiitori kombinatsioon h5-HT 1B antagonisti või osalise agonistiga
NO20006488D0 (no) Sammensetning og anvendelse
DK0736525T3 (da) Benzonitriler som 5-HT-agonister og -antagonister
IS4585A (is) Samsetning 5-HT upptöku-hemils og valkvæðs 5-HT 1A -mótlyfs
NO20004355D0 (no) Retarderende systemer og anvendelse derav ved oljebrønnsementering
GB9926862D0 (en) Corrosion inhibitor compositions and methods of making them
NO983481D0 (no) Sementadditiver og sementsammensetninger som omfatter nevnte additiver
PT826679E (pt) Compostos de naftilo intermediarios composicoes e metodos de utilizacao
PT1194038E (pt) Composicao de quebra do repouso e sua utilizacao
IS5408A (is) Samsetning valvísra 5-HT1A mótlyfja og valvíss h5-HT1B mótlyfs eða gerandefnis með hlutaverkun
PL366012A1 (pl) Kompozycja i sposób oznaczania glikozydazy
ID23757A (id) Komposisi bahan penyempurna
NO973047L (no) Elastiske brönnsementsammensetninger og fremgangsmåter
IS7277A (is) Samsetning kjörvíss PDE4 hindra og adrenergísks beta-2 viðtaka gerandefnis
SI1237553T1 (sl) Kombinacija inhibitorja ponovnega navzema serotonina in antagonista 5-ht 2c?, inverznega agonista ali delnega agonista
SI1014985T1 (en) A combination of a 5-ht reuptake inhibitor and a h5-ht 1b antagonist or partial agonist
DK1115389T3 (da) Fructosamin-oxidase: antagonister og inhibitorer
IT1306006B1 (it) Composizione sostitutiva dell'acqua specialmente per decori sumetacromotipie e applicazione.